{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T14:10:46Z","timestamp":1685455846155},"reference-count":0,"publisher":"Portico","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2018.54.8.2834461","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T05:43:37Z","timestamp":1535435017000},"page":"457","source":"Crossref","is-referenced-by-count":0,"title":["An update of lanreotide acetate for treatment of adults with\ncarcinoid syndrome"],"prefix":"10.3730","volume":"54","author":[{"family":"Guadalupe, E.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Deshpande, H.A.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Stein, S.M.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2018]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:35:21Z","timestamp":1685453721000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dd5hmw"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":0,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2018.54.8.2834461","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}